G. Witzany: The viral origins of telomeres and telomerases and their important role in eukaryogenesis and genome maintenance. In: Biosemiotics. Band1, 2008, S.191–206, doi:10.1007/s12304-008-9018-0.
Coles LS, Young RD: Supercentenarians and transthyretin amyloidosis: the next frontier of human life extension. In: PREVENTATIVE MEDICINE. Band54, Suppl, 2012, S.s9-s11, doi:10.1016/j.ypmed.2012.03.003, PMID 22579241.
D. Joshi, R. Gupta, A. Dubey, A. Shiwalkar, P. Pathak, R. C. Gupta, V. Chauthaiwale, C. Dutt: TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes. In: Journal of cardiovascular pharmacology. Band 54, Nummer 1, Juli 2009, S. 72–81, doi:10.1097/FJC.0b013e3181ac3a34, PMID 19546815.
K. P. Chandra, A. Shiwalkar et al.: Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects. In: Clinical drug investigation. Band 29, Nummer 9, 2009, S. 559–575, doi:10.2165/11315260-000000000-00000, PMID 19663519.
Ezio Giacobini, Gabriel Gold: Alzheimer disease therapy—moving from amyloid-β to tau. In: Nature Reviews Neurology. Band9, Nr.12, Dezember 2013, S.677–686, doi:10.1038/nrneurol.2013.223.
Szilard L: ON THE NATURE OF THE AGING PROCESS. In: Proc. Natl. Acad. Sci. U.S.A. Band45, Nr.1, Januar 1959, S.30–45, PMID 16590351, PMC 222509 (freier Volltext).
Harman D: The biologic clock: the mitochondria? In: J Am Geriatr Soc. Band20, Nr.4, April 1972, S.145–7, PMID 5016631.
STREHLER BL, MARK DD, MILDVAN AS: GEE MV: Rate and magnitude of age pigment accumulation in the human myocardium. In: J Gerontol. Band14, Oktober 1959, S.430–439, PMID 13835175.
MOVAT HZ, MORE RH, HAUST MD: The diffuse intimal thickening of the human aorta with aging. In: Am. J. Pathol. Band34, Nr.6, 1958, S.1023–1031, PMID 13583094, PMC 1934788 (freier Volltext).
Monnier VM, Cerami A: Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. In: Science. Band211, Nr.4481, Januar 1981, S.491–493, PMID 6779377.
BRODY H: Organization of the cerebral cortex. III. A study of aging in the human cerebral cortex. In: J. Comp. Neurol. Band102, Nr.2, April 1955, S.511–516, PMID 14381544.
HAYFLICK L: THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. In: Exp. Cell Res. Band37, März 1965, S.614–636, PMID 14315085.
Harman D: The biologic clock: the mitochondria? In: J Am Geriatr Soc. Band20, Nr.4, April 1972, S.145–147, PMID 5016631.
Coles LS, Young RD: Supercentenarians and transthyretin amyloidosis: the next frontier of human life extension. In: PREVENTATIVE MEDICINE. Band54, Suppl, 2012, S.s9-s11, doi:10.1016/j.ypmed.2012.03.003, PMID 22579241.
D. Joshi, R. Gupta, A. Dubey, A. Shiwalkar, P. Pathak, R. C. Gupta, V. Chauthaiwale, C. Dutt: TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes. In: Journal of cardiovascular pharmacology. Band 54, Nummer 1, Juli 2009, S. 72–81, doi:10.1097/FJC.0b013e3181ac3a34, PMID 19546815.
K. P. Chandra, A. Shiwalkar et al.: Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects. In: Clinical drug investigation. Band 29, Nummer 9, 2009, S. 559–575, doi:10.2165/11315260-000000000-00000, PMID 19663519.
